Published by the Journal for Clinical Studies
Volume 15 Issue 1
Mar 30, 2023
The imperative to obtain a diverse body of clinical trial participants has been stressed in public statements for decades; however, parties executing clinical trials have remained insufficiently effective in addressing it. Understanding the patterns unveiled in this study’s analyses can inform policies and programs designed to effectively encourage personnel to make diversity-oriented decisions.
Authors
Denise Calaprice, PhD
Senior Consultant, WCG Avoca
Ryan Whitty
Research Assistant, University of California, Berkeley
Christina Moon
Clinical Research Associate, Brain Inflammation Collaborative, Inc.
Neva Hidajat
Clinical Research Intern, Brain Inflammation Collaborative, Inc.
WCG assists sponsors in achieving an appropriately diverse and inclusive patient population in their clinical trials as a trusted partner to the life sciences industry. Request a consultation with our Diversity and Inclusion experts today:
Are you ready to transform the diversity of your clinical trials?
Use this form to request a consultation with WCG's Diversity, Equity & Inclusion experts.